# Aprepitant in the Management of Biological Therapies-related Severe Pruritus

> **NCT01683552** · PHASE2 · COMPLETED · sponsor: **Campus Bio-Medico University** · enrollment: 45 (actual)

## Conditions studied

- ITCH

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Prednisone
- **DRUG:** Fexofenadine

## Key facts

- **NCT ID:** NCT01683552
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683552, "Aprepitant in the Management of Biological Therapies-related Severe Pruritus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01683552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*